Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance

Hannah Åbacka, Jesper S Hansen, Peng Huang, Raminta Venskutonytė, Axel Hyrenius-Wittsten, Giulio Poli, Tiziano Tuccinardi, Carlotta Granchi, Filippo Minutolo, Anna K Hagström-Andersson, Karin Lindkvist-Petersson

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1163-1166
JournalHaematologica
Volume106
Issue number4
DOIs
Publication statusPublished - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Subject classification (UKÄ)

  • Cancer and Oncology

Free keywords

  • Antimetabolites, Antineoplastic/therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols/therapeutic use
  • Cytarabine/therapeutic use
  • Glucose Transporter Type 1/genetics
  • Humans
  • Leukemia, Myeloid, Acute/drug therapy

Cite this